Actuate Therapeutics, Inc (ACTU) insider trading
Every open-market stock purchase and sale by Actuate Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $1.6M over the last 12 months (1 sale). No open-market buys.
- Last insider buy: Leslie W. Kreis (10% owner), n/a, 15 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.6M (1 sale). Last close $1.95 on Jun 10, 2026.
Recent ACTU insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 21, 2026 | Aaron G.L. Fletcher (10% owner) | Bought (not open market) | — |
| May 21, 2026 | Amy L Ronneberg (Director) | Bought (not open market) | — |
| May 21, 2026 | Jason A Keyes (Director) | Bought (not open market) | — |
| May 21, 2026 | Martin H. Huber Jr. (Director) | Bought (not open market) | — |
| May 21, 2026 | Todd S Thomson (10% owner) | Bought (not open market) | — |
| May 21, 2026 | Roger Sawhney (Director) | Bought (not open market) | — |
| May 21, 2026 | Dan Zabrowski (Director) | Bought (not open market) | — |
| Apr 1, 2026 | Paul J Lytle (CFO) | Bought (not open market) | — |
| Apr 1, 2026 | Andrew Paul Mazar (COO) | Bought (not open market) | — |
| Apr 1, 2026 | Daniel M Schmitt (CEO) | Bought (not open market) | — |
| Feb 13, 2026 | Daniel M Schmitt (CEO) | Sold (not open market) | $528K |
| Feb 13, 2026 | Daniel M Schmitt (CEO) | Bought (not open market) | — |
| Jan 5, 2026 | Todd S Thomson (Insider) | Sold | $1.6M |
Who's trading ACTU
- Amy L Ronneberg, Director: other filings, last May 21, 2026
- Martin H. Huber Jr., Director: other filings, last May 21, 2026
- Roger Sawhney, Director: other filings, last May 21, 2026
- Jason A Keyes, Director: other filings, last May 21, 2026
- Dan Zabrowski, Director: other filings, last May 21, 2026
- Aaron G.L. Fletcher, 10% owner: other filings, last May 21, 2026
- Todd S Thomson, Director: sold $1.6M (1 sale), last May 21, 2026
- Andrew Paul Mazar, COO: other filings, last Apr 1, 2026
- Paul J Lytle, CFO: other filings, last Apr 1, 2026
- Daniel M Schmitt, CEO: other filings, last Apr 1, 2026
Get free alerts when an insider at Actuate Therapeutics, Inc files a new trade →